Found 14 matching trials
Harmonic Ratio in Patients With GLUT1 Deficiency Syndrome
N/AGlucose transporter deficiency syndrome type 1 (GLUT1DS) is a rare, genetic...
Status
Active Not Recruiting
Location
Child and Adolescent Epileptology Center
Triheptanoin (UX007) to Treat Citrate Transporter Deficiency
N/AThe purpose of this study is to determine whether triheptanoin (UX007) is e...
Status
No Longer Available
Location
Department of Neurology, Boston Children's Hospital
Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
PHASE2The purpose of this project is to study the efficacy of triheptanoin oil in...
Location
Brain and Spine Institute
Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
NAThe study aims at validating the diagnostic performances of the METAglut1, ...
Location
Hôpital Larrey- CHU Angers
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
PHASE2This is a single-center, randomized, double-blind, placebo-controlled, cros...
Location
Oregon Health and Science University
Evaluation of Krio in Children and Adults With Epilepsy
NAAcceptability study to evaluate the gastrointestinal tolerance, palatabilit...
Location
Multiple Locations
Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)
PHASE2The primary objective of the study is to evaluate the long-term safety of U...
Location
Children's Hospital Colorado - University of Colorado, Denver, School of Medicine
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
PHASE2This study is being done to assess the safety and long-term efficacy of tri...
Location
Cook Childrens Medical Center
Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
PHASE2The primary objectives of the study are to evaluate the efficacy of UX007 c...
Location
Children's Hospital Colorado - University of Colorado, Denver, School of Medicine
Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
N/AThis treatment plan is intended for the use of UX007 (triheptanoin) in the ...
Status
No Longer Available
Location
Children's Hospital of Pittsburgh of UPMC